ABI, Affy, GE, NIAID Among Eight Groups to Act as ERCC RNAi Testing Sites | GenomeWeb
NEW YORK (GenomeWeb News) – The External RNA Controls Consortium today said that eight testing sites have registered for the initial phase of the RNA control testing initiative.
 
The participants are: Affymetrix, Agilent, Applied Biosystems, GE Healthcare, Illumina, National Institute of Allergy and Infectious Diseases, Qiagen, and Roche Molecular Systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.